Steroid Therapy of Septic Shock

Critical Care Nursing Clinics of North America

Volumn 23, Issue 1, 2011, Pages 171-180

  Sprung, Charles L ^a   Goodman, Serge ^a   Weiss, Yoram G ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Corticosteroids; Mortality; Septic shock; Shock reversal; Steroids

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID;

DOSE RESPONSE; HUMAN; INTENSIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SEPTIC SHOCK; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CRITICAL CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 79751488469     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2010.12.010     Document Type: Review

References (34)

1. Schein R.M.H., Sprung C.L. The use of corticosteroids in the sepsis syndrome. Critical Care - State of the Art 1986, vol. 14 1986, The Society of Critical Care Medicine, Fullerton (CA), p. 131-49.
2. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976, 184:333-341.
3. Sprung C.L., Caralis P.V., Marcial E.H., et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984, 311:1137-1143.
4. Bone R.C., Fisher C.J., Clemmer T.P., et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658.
5. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987, 317:659-665. The Veterans Administration Systemic Sepsis Cooperative Study Group.
6. Lefering R., Neugebauer E.A.M. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995, 23:1294-1303.
7. Cronin L., Cook D.J., Carlet J., et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 24:1430-1439.
8. Slotman G.J., Fisher C.J., Bone R.C., et al. Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1993, 21:191-195.
9. Lamberts S.W.J., Bruining H.A., de Jong F.H. Corticosteroid therapy in severe illness. N Engl J Med 1997, 337:1285-1292.
10. Bollaert P.E., Charpentier C., Levy S., et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650.
11. Briegel J., Frost H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single center study. Crit Care Med 1999, 27:723-732.
12. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-870.
13. Keh D., Boehnke T., Weber-Cartens S., et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167(4):512-520.
14. Oppert M., Schindler R., Husung C., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005, 33:2457-2464.
15. Cicarelli D.D., Viera J.E., Martin Besenor F.E. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J 2007, 125:237-241.
16. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288:2859-2867.
17. Herridge M.S., Cheung A.M., Tansey C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693.
18. Bone R.C. The pathogenesis of sepsis. Ann Intern Med 1991, 115:457-469.
19. Annane D., Bellissant E., Sebille V., et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal reserve. Br J Clin Pharmacol 1998, 46:589-597.
20. Annane D., Sebille V., Trocke G., et al. A 3-level prognostic classification of septic shock based on cortisol level and cortisol response to corticotropin. JAMA 2000, 283:1038-1045.
21. Dellinger P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for the management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873.
22. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004, 329:480-488.
23. Minneci P.C., Deans K.J., Banks S.M., et al. Meta-analysis: the effects of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004, 141:47-56.
24. Sprung C.L., Annane D., Keh D., et al. The CORTICUS randomized, double-blind, placebo-controlled study of hydrocortisone therapy in patients with septic shock. N Engl J Med 2008, 358:111-124. Corticus Study Group.
25. Heininger A., Jahn J., Engel C., et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001, 29:541-547.
26. Jaber S., Chanques G., Borry J., et al. Cytomegalovirus infection in critically ill patients. Chest 2005, 127:233-241.
27. Peter J.V., John P., Graham P.L., et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. Br Med J 2008, 336:1006-1009.
28. Marik P.E., Pastores S.M., Annane D., et al. Clinical practice guidelines for the diagnosis and management of corticosteroid insufficiency in critical illness: recommendations of an international task force. Crit Care Med 2008, 36:1937-1949.
29. Silverman H.J., Penaranda R., Orens J.B., et al. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993, 21:31-39.
30. Saito T., Takanashi M., Gallagher E., et al. Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 1995, 21:204-210.
31. Perla D., Marmorston J. Suprarenal cortical hormone and salt in the treatment of pneumonia and other severe infections. Endocrinology 1940, 27:367-374.
32. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
33. Russell J.A., Walley K.R., Gordon A.C., et al. Interaction of vasopressin infusion, corticosteroid treatment and mortality of septic shock. Crit Care Med 2009, 37:811-818.
34. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.